Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valethamate Bromide vs Hyoscine Butyl Bromide for Reducing Labor Duration in Primigravida
NCT07474350Completed
- Sponsor
- Alex Ekwueme Federal University Teaching Hospital
- Start
- Sep 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of valethamate in prolonged labor (3 arms), sponsored by Alex Ekwueme Federal University Teaching Hospital. Primary endpoint: Rate of cervical dilatation at 8 hours. Started Sep 2023; status: completed.
02
Drugs
valethamate
03
Conditions
prolonged labor
Beyond the preview
Go deeper on NCT07474350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07474350.